21st Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

April 2024 | 2450 pages | ID: 222594BD2D58EN
BioPlan Associates, Inc.

Abstracts

The 2024 21st Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is the most comprehensive, longest-running study of bioprocessing professionals. We highlight industry trends, insights, and opportunities. NEW! This year’s edition provides additional Subject Matter Experts providing analysis on trends and future growth, and key takeaways in each chapter! This report’s 505 pages of data-rich analysis will help improve your decision making in biomanufacturing operations, with an in-depth analysis of capacity, production trends, benchmarks, and much more.

Contents

Overview
Methodology
CHAPTER 0: Demographics
CHAPTER 1: Introduction and Discussion
CHAPTER 2: Overview of Critical Issues in Bioprocessing
CHAPTER 3: Emerging Issues in Biopharmaceutical Manufacturing
CHAPTER 4: Capacity Utilization
CHAPTER 5: Current and Future Capacity Constraints
CHAPTER 6: Future Capacity Expansions
CHAPTER 7: Outsourcing Trends in Biopharmaceutical Manufacturing
CHAPTER 8: Disposables and Single-Use Systems in Biopharmaceutical Manufacturing
CHAPTER 9: Downstream Purification
CHAPTER 10: Hiring, Employment Growth and Training in Biopharmaceutical Manufacturing
CHAPTER 11: New Methods: Continuous and Process Intensification, Cell and Gene Therapies
CHAPTER 12: Suppliers to Biopharmaceutical Manufacturing and Life Sciences